Last edition
News about "New Drug Permission"
Biodeal Pharmaceuticals Secures CDSCO Approval for Indigenous Midazolam Nasal Spray
Biodeal Pharmaceuticals has received CDSCO New Drug Permission for its indigenously developed midazolam nasal spray 1.25 percent w/v, marking the first approval of this product and strength in India.
New Drug Permission | 12/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members